FDA.reportPublic FDA data

NDC 71719-2040 - Vizumax ENEM

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
71719-2040
Package NDCs from labels
71719-2040-1, 71719-2040-2
Manufacturer
Vizumax Diagnostics LLC
Effective date
2021-10-04
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Vizumax ENEM - Vizumax Diagnostics LLCVizumax Diagnostics LLC2021-10-04HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
71719-2040-12022-07-29These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2040-22022-07-29These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2040-12021-10-04These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2040-22021-10-04These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2040-12021-01-29These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2040-22021-01-29These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71719-2040-1Vizumax ENEM454 g in 1 BAGPOWDER, FOR SUSPENSION4544
71719-2040-2Vizumax ENEM397 g in 1 BAGPOWDER, FOR SUSPENSION3974

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71719-2040VIZUMAX ENEM (BARIUM SULFATE) POWDER, FOR SUSPENSION [VIZUMAX DIAGNOSTICS LLC]42 package rows20211005_2a9517f0-533c-4a22-88ab-e0aa5fd57b4d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 8 · 145 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Varibar Thin LiquidBARIUM SULFATEE-Z-EM Canada Inc59493c83-3941-cc84-cc37-a8696ae428732026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Readi-Cat 2 Berry SmoothieBARIUM SULFATEE-Z-EM Canada Incd2d293d5-dcc9-0d3f-58ed-686ef0132d7c2026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
E-Z-HDBARIUM SULFATEE-Z-EM Canada Inca4330804-7179-472a-91cb-84bbd5079bb82026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Tagitol VBARIUM SULFATEE-Z-EM Canada Inc30c68756-c7db-bf50-9cd5-ef4b0c7ab1d02026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Sodium Citrate and Citric AcidSODIUM CITRATE AND CITRIC ACIDChartwell Governmental & Specialty RX, LLC58c24504-47de-487a-ab8d-18add155ea952026-04-07Adverse reactionsExact identifier
unii: 1Q73Q2JULR
Lubricant Eye DropsCARBOXYMETHYLCELLULOSE SODIUMKC Pharmaceuticals, Inc.4d1d9b3a-ac5f-db27-e063-6294a90afc3f2026-03-16WarningsExact identifier
unii: K679OBS311
Lubricant Eye DropsCARBOXYMETHYLCELLULOSE SODIUMRedicare LLC4d1e5089-22b0-7b3f-e063-6294a90a346a2026-03-16WarningsExact identifier
unii: K679OBS311
Rain Renewal Eye DropsCARBOXYMETHYLCELLULOSE SODIUMRain Eye Drops, LLCbb451b22-c4f6-291d-e053-2a95a90a78012026-03-06WarningsExact identifier
unii: K679OBS311
Refresh Optive Mega-3 PFCARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80Allergan, Inc.326cb5d6-c784-404f-9a13-6d69262dda6e2026-03-01WarningsExact identifier
unii: K679OBS311
Discount Drug Mart Lubricant Eye DropsCARBOXYMETHYLCELLULOSE SODIUMDiscount Drug Mart4ba1b369-54e2-5224-e063-6394a90a47692026-02-25WarningsExact identifier
unii: K679OBS311
TricitratesTRICITRATESChartwell Governmental & Specialty RX, LLC.c4ff0407-3930-4c48-afd4-d2cb3e1b18f42026-02-25Warnings, Adverse reactionsExact identifier
unii: 1Q73Q2JULR
Lubricant Eye DropsCARBOXYMETHYLCELLULOSE SODIUMKC Pharmaceuticals, Inc.4bafa882-50b7-e3e2-e063-6294a90a76e32026-02-25WarningsExact identifier
unii: K679OBS311
Sodium Citrate and Citric AcidSODIUM CITRATE AND CITRIC ACID MONOHYDRATEAtlantic Biologicals Corp.42d837ae-2578-46df-92d2-24774964aaad2026-01-28Adverse reactionsExact identifier
unii: 1Q73Q2JULR
Carboxymethylcellulose Sodium Eye Drops 0.5%CARBOXYMETHYLCELLULOSE SODIUM EYE DROPS 0.5%Aurolabe8b4df3b-3d81-b3ca-e053-2a95a90af2ec2026-01-27WarningsExact identifier
unii: K679OBS311
AURO-CMCCARBOXYMETHYLCELLULOSE EYE DROPS 0.5%Aurolabe90b397f-fe64-8674-e053-2995a90a223f2026-01-27WarningsExact identifier
unii: K679OBS311
Family Care Single Use Lubricant Eye Drop 0.4mL 5ctCARBOXYMETHYLCELLULOSE SODIUMUnited Exchange Corp48879feb-b5ae-a9e6-e063-6394a90a03b22026-01-16WarningsExact identifier
unii: K679OBS311
Family Care Single Use Lubricant Eye Drop 0.4mL 30ctCARBOXYMETHYL CELLULOSE 0.5%United Exchange Corp488b3363-8d06-7dcc-e063-6294a90ab44c2026-01-16WarningsExact identifier
unii: K679OBS311
carboxymethylcellulose sodiumCARBOXYMETHYLCELLULOSE SODIUMAvPAKb4697319-438e-2ec8-e053-2a95a90abb562026-01-08WarningsExact identifier
unii: K679OBS311
carboxymethylcellulose sodiumCARBOXYMETHYLCELLULOSE SODIUMAvPAKb478a695-ded0-2e5f-e053-2995a90ac45e2026-01-08WarningsExact identifier
unii: K679OBS311
TheraTears Dry and TiredCARBOXYMETHYLCELLULOSE SODIUMMEDTECH PRODUCTS INC02b70e2d-8159-4637-a282-9eac1468e7862026-01-07WarningsExact identifier
unii: K679OBS311

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.